Aim: To evaluate the benefits of macular translocation with 360 degree retinotomy in patients with exudative age related macular degeneration (ARMD). Methods: A consecutive interventional case series was performed on patients who underwent macular translocation between June 1997 and January 2000 at the department of ophthalmology, University of Aachen, Germany. A retrospective pilot study was s...

Recent developments may provide an opportunity to improve outcome in individuals who develop neovascular age-related macular degeneration (ARMD). Several therapies have been introduced that show promise for halting the progression of this disorder. However, data from controlled clinical trials to test the relative efficacy of different management strategies across the subtypes of disease remain...

AIM To evaluate the benefits of macular translocation with 360 degree retinotomy in patients with exudative age related macular degeneration (ARMD). METHODS A consecutive interventional case series was performed on patients who underwent macular translocation between June 1997 and January 2000 at the department of ophthalmology, University of Aachen, Germany. A retrospective pilot study was s...

We've been finding possible association of central vision damage with binocular vision disorders in our clients suffering from age-related macular degeneration (ARMD), but whose visual acuity still allowed us to examine their binocular vision. Our findings show that there is a significant number of patients with heterophoria in horizontal, as well as vertical direction. The clients rate the vis...

We have read with interest the article by Dr. Filloy and Arias1 under the title “Response to ranibizumab in patients with wet age-related macular degeneration (ARMD) with vitreomacular traction” in which they conclude that in these patients the tendency is to diminished visual acuity, requiring a higher number of intravitreal injections. Recently, Mayr-Sponer et al.2 published a paper under the...

Doctors and the public considerably underestimate the negative impact of age related macular degeneration (ARMD) on health related quality of life. (Br J Ophthalmol 2003;87:8–12) The progressive nature of ARMD prevents participation in many everyday activities, such as reading and driving, and it is also the most common cause of blindness in elderly people. A standardised questionnaire created ...

Age-related macular degeneration (ARMD) is the leading cause of irreversible visual loss in the Western world, affecting approximately 25 million people worldwide. The pathogenesis is complex and missense mutations in FBLN5 have been reported in association with ARMD. We have investigated the role of fibulin 5 in ARMD by completing the first European study of the gene FBLN5 in ARMD (using 2 Eur...

Blood samples were analyzed for GSH and GSH redox state in 40 age-related macular degeneration (ARMD) patients (> 60 y), 33 non-ARMD diabetic patients (> 60 years), 27 similarly aged non-ARMD and nondiabetic individuals (> 60 years), and 19 younger individuals (< 60 years) without ARMD or diabetes. Results showed a significantly lower plasma GSH in older individuals (ARMD, diabetes, and control...

Macular degeneration is one of the most common retinal diseases in India. Usually it is observed in people over 60s and is therefore called age related Macular degeneration, ARMD or AMD. The macula is responsible for the sharp central vision needed for detailed activities such as reading, writing, driving, face recognition and ability to see colours. Age related macula degeneration is degenerat...